Watch leading experts discuss the diagnosis and management of spinal muscular atrophy (SMA), including causes of diagnostic delay, emerging treatment approaches and the crucial role of the multidisciplinary team in the management of this disease.
Dr Nancy Kuntz (Ann & Robert H. Lurie Children’s Hospital of Chicago) discusses the diagnosis of SMA, Dr Eduardo Tizzano (Hospital Vall d’Hebron, Barcelona) reviews clinical management and emerging therapeutic options, and Dr Oscar H. Mayer (The Children’s Hospital of Philadelphia) describes the crucial role of multidisciplinary management.
This activity is intended for neurologists, paediatricians, pulmonologists, primary care physicians and other healthcare professionals involved in the treatment of patients with SMA.
After watching this touchEXPERT OPINIONS, you should be able to:
- Identify patients at risk of spinal muscular atrophy (SMA) through genetic screening and recognize early symptoms in the disease course
- Describe key trial and registry data (including antisense oligonucleotide and gene therapy) supporting improved treatment practice and outcomes in SMA patients
- Discuss roles within the multidisciplinary team (MDT) and impact of a standardized treatment approach across the MDT including utilization of guidelines and treatment innovations for SMA patients in clinical practice